FINGER ALISON CECILY

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$397,153.14

Insider Activity of FINGER ALISON CECILY

The largest sale of all time was on 2020-01-07 and amounted to 1049 shares of bluebird bio, Inc. for $94,380.

Biography of FINGER ALISON CECILY

No biography is available at this moment.

2021-01-06Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
1,814
0.0027%
$45.05$81,727-38.77%
2021-01-05Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
40
<0.0001%
$44.95$1,798-38.73%
2020-12-02Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
36
<0.0001%
$46.20$1,663-36.66%
2020-11-02Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
35
<0.0001%
$52.99$1,855-43.38%
2020-10-02Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
36
<0.0001%
$52.77$1,900-39.92%
2020-09-03Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
35
<0.0001%
$58.60$2,051-44.93%
2020-08-03Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
35
<0.0001%
$60.49$2,117-30.45%
2020-07-02Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
36
<0.0001%
$61.57$2,217-23.38%
2020-06-02Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
35
<0.0001%
$64.04$2,241-28.14%
2020-01-07Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
1,049
0.0019%
$89.97$94,380-36.13%
2020-01-03Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
517
0.0009%
$84.96$43,924-33.41%
2019-01-07Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
643
0.0012%
$113.64$73,068+6.88%
2019-01-03Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
476
0.0009%
$99.31$47,273+21.6%
2018-08-20Salebluebird bio, Inc.
BLUE
Chief Commercial Officer
259
0.0005%
$158.07$40,940-17.58%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.